Literature DB >> 32169220

Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

I Ray-Coquard1, P Morice2, D Lorusso3, J Prat4, A Oaknin5, P Pautier2, N Colombo6.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32169220     DOI： 10.1093/annonc/mdy001

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

Review 1.  Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium.

Authors:  Adriana Fonseca; João Lobo; Florette K Hazard; Joanna Gell; Peter K Nicholls; Robert S Weiss; Lindsay Klosterkemper; Samuel L Volchenboum; James C Nicholson; A Lindsay Frazier; James F Amatruda; Aditya Bagrodia; Michelle Lockley; Matthew J Murray
Journal:  Br J Cancer       Date:  2022-10-13       Impact factor: 9.075

2.  The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysis.

Authors:  Lu Ye; Li Cai; Yonghui Fu; Debao Zhuang; Xiaoqing Hu; Youkun Jie
Journal:  World J Surg Oncol       Date:  2021-01-13       Impact factor: 2.754

Review 3.  Female Germ Cell Development, Functioning and Associated Adversities under Unfavorable Circumstances.

Authors:  Dinesh Bharti; Manisha Tikka; Sang-Yun Lee; Eun-Yeong Bok; Hyeon-Jeong Lee; Gyu-Jin Rho
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

4.  Gynecologic Malignancies in Children and Adolescents: How Common is the Uncommon?

Authors:  Christoph Wohlmuth; Iris Wohlmuth-Wieser
Journal:  J Clin Med       Date:  2021-02-12       Impact factor: 4.241

Review 5.  Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition.

Authors:  Maria Fernanda Evangelista Simões; Alexandre André Balieiro Anastácio da Costa; Tullio Novaes Silva; Lizieux Fernandes; Graziele Bovolim; Giovana Tardin Torrezan; Dirce Maria Carraro; Glauco Baiocchi; Ademir Narcizo Oliveira Menezes; Elizabeth Santana Dos Santos; Louise De Brot
Journal:  Curr Oncol       Date:  2022-01-18       Impact factor: 3.677

6.  Could fertility-sparing surgery be considered for stage I ovarian sex cord-stromal tumors? A comparison of the Fine-Gray model with Cox model.

Authors:  Dan Sun; Zhi F Zhi; Jiang T Fan
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

Review 7.  Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials.

Authors:  E Panagiotou; G Gomatou; I P Trontzas; N Syrigos; E Kotteas
Journal:  Clin Transl Oncol       Date:  2021-08-07       Impact factor: 3.405
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.